文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

miR-155-5p/轴通过mTOR途径抑制胃癌进展。

The miR-155-5p/ axis inhibits the progression of gastric cancer via the mTOR pathway.

作者信息

Yuan Tao, Liu Haiyan, Li Fangfang, Meng Qingyue, Wang Yajuan, Yuan Mei

机构信息

Hospital Office, The No. 3 People's Hospital of Qingdao, Qingdao, China.

Department of Dermatology, The No. 8 People's Hospital of Qingdao, Qingdao, China.

出版信息

Transl Cancer Res. 2025 Feb 28;14(2):1375-1387. doi: 10.21037/tcr-2025-8. Epub 2025 Feb 26.


DOI:10.21037/tcr-2025-8
PMID:40104748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11912068/
Abstract

BACKGROUND: Gastric cancer (GC) is a leading cause of cancer-related death. MicroRNAs (miRNAs or miRs) play a crucial role in the pathology of GC, including cell proliferation, invasion, and metastasis. In this study, genes targeted by miR-155-5p were predicted using bioinformatic tools. We found that the expression of miR-155-5p in GC cell lines differed relative to the expression of F-box protein 11 (), which is involved in the regulation of cellular processes. This study sought to examine the function of miR-155-5p and the precise mechanism underlying its regulatory function in modulating proliferation and apoptosis in GC. METHODS: The luciferase reporter assay results showed that miR-155-5p bound directly to the three prime untranslated region (3'-UTR) of , which further downregulated expression. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western-blot analyses confirmed that miR-155-5p negatively regulated the messenger RNA (mRNA) and protein expression of . The effects of on cell proliferation and apoptosis in GC cell lines was further examined using Cell Counting Kit-8 (CCK-8) and flow cytometry. RESULTS: We found that promoted proliferation and decreased apoptosis in GC cells. Conversely, rescue experiments showed that the knockdown of limited the effects of miR-155-5p on the proliferation and apoptosis of GC cells, providing further evidence that is a functional target of miR-155-5p. Further, the overexpression of miR-155-5p inhibited cell growth via the targeted inhibition of that regulated mammalian target of rapamycin (mTOR) signaling pathway in the GC cells. CONCLUSIONS: Overall, these results showed that miR-155-5p may serve as a tumor suppressor in GC and that the miR-155-5p/ axis regulates tumor progression via the mTOR signaling pathway. Consequently, our findings may lead to the development a novel treatment strategy for GC.

摘要

背景:胃癌(GC)是癌症相关死亡的主要原因。微小RNA(miRNA或miR)在胃癌的病理过程中发挥着关键作用,包括细胞增殖、侵袭和转移。在本研究中,使用生物信息学工具预测了miR-155-5p靶向的基因。我们发现,与参与细胞过程调节的F-box蛋白11()的表达相比,miR-155-5p在胃癌细胞系中的表达有所不同。本研究旨在探讨miR-155-5p的功能及其在调节胃癌细胞增殖和凋亡中发挥调节作用的精确机制。 方法:荧光素酶报告基因检测结果表明,miR-155-5p直接与的3'非翻译区(3'-UTR)结合,进而下调的表达。定量逆转录-聚合酶链反应(qRT-PCR)和蛋白质免疫印迹分析证实,miR-155-5p负向调节的信使核糖核酸(mRNA)和蛋白质表达。使用细胞计数试剂盒-8(CCK-8)和流式细胞术进一步检测了对胃癌细胞系细胞增殖和凋亡的影响。 结果:我们发现促进胃癌细胞增殖并减少其凋亡。相反,挽救实验表明,敲低可限制miR-155-5p对胃癌细胞增殖和凋亡的影响,进一步证明是miR-155-5p的功能靶点。此外,miR-155-5p的过表达通过靶向抑制调节胃癌细胞中雷帕霉素靶蛋白(mTOR)信号通路的来抑制细胞生长。 结论:总体而言,这些结果表明miR-155-5p可能作为胃癌中的肿瘤抑制因子,并且miR-155-5p/轴通过mTOR信号通路调节肿瘤进展。因此,我们的发现可能会导致开发一种新的胃癌治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/1c85cdd354a1/tcr-14-02-1375-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/0a0528dd4e5d/tcr-14-02-1375-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/b3ca3d9783f7/tcr-14-02-1375-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/ebca62f8acc0/tcr-14-02-1375-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/543859276066/tcr-14-02-1375-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/1c85cdd354a1/tcr-14-02-1375-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/0a0528dd4e5d/tcr-14-02-1375-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/b3ca3d9783f7/tcr-14-02-1375-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/ebca62f8acc0/tcr-14-02-1375-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/543859276066/tcr-14-02-1375-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bb2/11912068/1c85cdd354a1/tcr-14-02-1375-f5.jpg

相似文献

[1]
The miR-155-5p/ axis inhibits the progression of gastric cancer via the mTOR pathway.

Transl Cancer Res. 2025-2-28

[2]
miR-181a-5p inhibits the proliferation and invasion of drug-resistant glioblastoma cells by targeting F-box protein 11 expression.

Oncol Lett. 2020-11

[3]
Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.

J Exp Clin Cancer Res. 2017-4-21

[4]
MiR-129-5p inhibits proliferation of gastric cancer cells through targeted inhibition on HMGB1 expression.

Eur Rev Med Pharmacol Sci. 2020-4

[5]
inhibits gastric cancer progression the serpin family E member 1- extracellular signal-regulated kinase-1/2 axis.

World J Gastrointest Oncol. 2024-5-15

[6]
Long non-coding RNA KCNQ1OT1 promotes the progression of gastric cancer via the miR-145-5p/ARF6 axis.

J Gene Med. 2021-5

[7]
Restrains Apatinib Resistance in Human Gastric Cancer Cells Via Downregulating .

Cancer Biother Radiopharm. 2021-2

[8]
MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer.

Biomed Pharmacother. 2020-8

[9]
MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK.

Cancer Manag Res. 2020-9-8

[10]
Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.

J Gastroenterol Hepatol. 2021-7

本文引用的文献

[1]
Stomach microbiota in gastric cancer development and clinical implications.

Gut. 2024-11-11

[2]
Circulating miRNA and circulating tumor DNA application as liquid biopsy markers in gastric cancer.

Clin Biochem. 2024-7

[3]
MiRNA-766-3p inhibits gastric cancer via targeting COL1A1 and regulating PI3K/AKT signaling pathway.

J Cancer. 2024-1-1

[4]
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease.

Signal Transduct Target Ther. 2023-10-2

[5]
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.

Mol Cancer. 2023-8-18

[6]
FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.

Proc Natl Acad Sci U S A. 2023-6-13

[7]
Updates on global epidemiology, risk and prognostic factors of gastric cancer.

World J Gastroenterol. 2023-4-28

[8]
Tumor Necrosis Factor- Promotes the Tumorigenesis, Lymphangiogenesis, and Lymphatic Metastasis in Cervical Cancer via Activating VEGFC-Mediated AKT and ERK Pathways.

Mediators Inflamm. 2023

[9]
Expression and significance of miR-34 with PI3K, AKT and mTOR proteins in colorectal adenocarcinoma tissues.

Cell Mol Biol (Noisy-le-grand). 2022-9-30

[10]
Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the AKT/mTOR/S6K signalling pathway.

J Obstet Gynaecol. 2023-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索